Comparison of Danhong and Salvia Ligustrazin to adjust abnormal level of coagulation factor Ⅶ caused by ACS
10.3760/cma.j.issn.1673-4246.2010.01.023
- VernacularTitle:丹红与丹参川芎嗪注射液对急性冠状动脉综合征所致凝血因子Ⅶ异常的调节作用比较
- Author:
Huimin CHEN
;
Zhi LIU
- Publication Type:Journal Article
- Keywords:
Acme coronary syndrome;
Danhong injection;
Salvia Ligustrazin injection;
Coagulation factorⅦ
- From:
International Journal of Traditional Chinese Medicine
2010;32(1):47-48
- CountryChina
- Language:Chinese
-
Abstract:
Objective To compare the regulatory functions of Danhong and Salvia Ligustrazin on abnormal coagulation factors Ⅶ caused by ACS.Methods All cases were randomly divided into group A and B and a control group.Each group contains 60 patients.The control group was treated with conventional western therapies.On this basis,group A Was treated with Danhong injection and group B was treatedwith Salvia Ligustrazin injection.Compare the regulatory function of its group on abnormal level of coagulation factor Ⅶ caused by ACS.Results Group B showed better effects in its regulating abnormal level of coagulation factor Ⅶ as compaared to group A(χ~2=3.67,P<0.05).Both groups did better than the control group in adjusting coagulation factors Ⅶ (P<0.05).Conclusion Salvia ligustrazine has better effect in regulating coagulation factors Ⅶ than Dan Hong injection,which is better than conventional western medical therapy.